Measuring Droplets in Children
Not Applicable
Completed
- Conditions
- Droplet Spread
- Registration Number
- NCT04518033
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
This study will measure the size and quantity of respiratory particle production in children under a variety of conditions, including face coverings/masks and various common activities.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
- Age 3 to 17 years
Exclusion Criteria
- Chronic neuromuscular conditions that affect respiration
- Tracheostomy tube
- Unable to wear a face mask
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Respiratory particle production 2 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the efficacy of various face coverings in reducing respiratory droplet size and quantity in children with Droplet Spread disease?
How do different face mask materials impact aerosol particle dispersion in pediatric populations during common activities?
What are the comparative effectiveness of N95, surgical, and cloth masks in mitigating respiratory droplet transmission in children?
Are there specific biomarkers that correlate with higher respiratory particle production in children under mask intervention conditions?
What are the potential adverse events associated with prolonged face covering use in children and how can they be managed?
Trial Locations
- Locations (1)
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
Massachusetts General Hospital🇺🇸Boston, Massachusetts, United States